U. Dührsen

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

G. Ehninger, C. Thiede, U. Platzbecker, 2017, Leukemia.

GFI1 as a novel prognostic and therapeutic factor for AML/MDS

F. Robert, M. Heuser, T. Möröy, 2016, Leukemia.

Cost-effectiveness of shortening treatment duration based on interim PET outcome in patients with diffuse large B-cell lymphoma

A. Hüttmann, L. Ceriani, H. D. de Vet, 2021, Clinical Lymphoma Myeloma and Leukemia.

Interferon alpha (IFN) treatment of bone marrow stroma inhibits haematopoesis.

D. Beelen, A. Lübking, C. Kasper, 2004, Leukemia research.

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD‐1 inhibitors

J. Klode, D. Schadendorf, P. Jansen, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.

J. Villeval, D. Metcalf, G. Morstyn, 1988, Blood.